
View larger version (92K):
[in a new window]
|
Fig. 3. ash1a and ngn1 are important regulators of neurogenesis
in the epiphysis. A-F and I-L are dorsal views of the epiphysis with anterior
at the top. G and H are lateral views of the brain with anterior to the right.
(A-F) Expression of isl1 at the 25-somite stage in the epiphysis of
wild-type (WT), ash1a MO-,
ash1a5'UTR MO-,
ngn1MO-, ash1a and
ash1a5'UTRMO-, or
ash1a and ngn1 MO-injected embryos. Neuronal production was
reduced in ash1a morphants (B,C,E) but was normal in the
ngn1 morphant (D). A stronger effect was observed in the double
ash1a/ngn1 morphant (F) compared with single ash1a morphants
(B,C,E). A combination of
ash1a5'UTR MO and
ash1a MO gave rise to a similar phenotype (E) to the single
ash1a or ash1a5'UTR
morphants (B,C). (G,H) Expression of isl1 at 25 hours in the heads of
wild-type and ash1a-morphant embryos. The black arrowhead indicates
the nucleus of the posterior commissure and the white arrow indicates the
adenohypophysis (G); both are sites where isl1 expression is
disrupted in the ash1a morphant (H). A reduction of the number of
neurones was observed in the epiphysis of the ash1a morphant (H). By
contrast, structures in which ash1a is not expressed, like the
trigeminal ganglia, are not affected in the ash1a morphant. (I,J)
Expression of ngn1 in wild-type and ash1a-morphant embryos
at the 20s stage. (K,L) Expression of ash1a in wild-type and
ngn1-morphant embryos at the 17s stage. Hy, hypothalamus; Tg,
trigeminal ganglia. Scale bars: in A, 10 µm for A-F,I-L; in H, 50 µm for
G,H.
|